Episodes 16-30 of 746
Evaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
Project Oncology®Evaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Project Oncology®Predicting Prognosis in DLBCL: The Role of Immune-Related Gene Signatures
Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Project Oncology®Refining Risk, Reducing Burden: ENDORISK-2 and Preoperative Stratification in Endometrial Cancer
Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
Project Oncology®Relapsed or Refractory DLBCL: Reviewing the Expanding Treatment Landscape
Real-World CDK4/6 Inhibitor Patterns in HR+/HER2– Metastatic Breast Cancer
Project Oncology®Real-World CDK4/6 Inhibitor Patterns in HR+/HER2– Metastatic Breast Cancer
Selecting First-Line Therapy in Gastric Cancers: A Biomarker-Driven Approach
Project Oncology®Selecting First-Line Therapy in Gastric Cancers: A Biomarker-Driven Approach
- advertisement
Assessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
Project Oncology®Assessing Atirmociclib Plus Letrozole in HR+/HER2- Metastatic Breast Cancer
Axatilimab for cGVHD: Assessing Organ-Specific Responses in AGAVE-201
Project Oncology®Axatilimab for cGVHD: Assessing Organ-Specific Responses in AGAVE-201
Obesity and Cancer Screening: National Trends and Disparities Revealed
Clinician's RoundtableObesity and Cancer Screening: National Trends and Disparities Revealed
Managing MCL After BTKi Failure: The Expanding Role of CAR T-Cell Therapy
Project Oncology®Managing MCL After BTKi Failure: The Expanding Role of CAR T-Cell Therapy
Advancing MPE Diagnosis and Prognosis: Clinical Value of Biomarker Integration
Clinician's RoundtableAdvancing MPE Diagnosis and Prognosis: Clinical Value of Biomarker Integration
Chronic Graft-Versus-Host Disease Care: Evolving Therapeutic Strategies
Project Oncology®Chronic Graft-Versus-Host Disease Care: Evolving Therapeutic Strategies
- advertisement
Reevaluating Race in Spirometry: Advancing Equity in Pulmonary Risk Assessment
Project Oncology®Reevaluating Race in Spirometry: Advancing Equity in Pulmonary Risk Assessment
Modernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice
Project Oncology®Modernizing Pulmonary Assessment: Reassessing Race-Neutral Interpretation in Practice
Evaluating Axatilimab in Chronic GVHD: How Prior Therapies Impact Outcomes
Project Oncology®Evaluating Axatilimab in Chronic GVHD: How Prior Therapies Impact Outcomes
